|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,323.00 INR | -0.51% |
|
-4.43% | -1.08% |
| 14/11 | Divi's Labs Unit-I inspection by US FDA concluded | RE |
| 10/11 | Jefferies Adjusts Divi's Laboratories' Price Target to INR7,850 From INR7,150, Keeps at Buy | MT |
| Capitalization | 1,68700Cr 1.87TCr 1.61TCr 1.5TCr 1.39TCr 2.59TCr 2.78TCr 17TCr 6.78TCr 81TCr 7TCr 6.86TCr 2,95900Cr | P/E ratio 2026 * |
65.1x | P/E ratio 2027 * | 53.6x |
|---|---|---|---|---|---|
| Enterprise value | 1,65200Cr 1.83TCr 1.57TCr 1.47TCr 1.37TCr 2.54TCr 2.72TCr 17TCr 6.63TCr 79TCr 6.85TCr 6.71TCr 2,89700Cr | EV / Sales 2026 * |
15.4x | EV / Sales 2027 * | 13.1x |
| Free-Float |
47.79% | Yield 2026 * |
0.52% | Yield 2027 * | 0.57% |
Last Transcript: Divi's Laboratories Limited
| 1 day | -0.50% | ||
| 1 week | -4.43% | ||
| Current month | -1.08% | ||
| 1 month | -0.19% | ||
| 3 months | -4.20% | ||
| 6 months | -7.43% | ||
| Current year | -1.08% |
| 1 week | 6,316.5 |  | 6,635.5 |
| 1 month | 6,280.5 | | 6,731.5 |
| Current year | 6,316.5 | | 6,731.5 |
| 1 year | 4,955 | | 7,071.5 |
| 3 years | 2,730 | | 7,071.5 |
| 5 years | 2,730 | | 7,071.5 |
| 10 years | 532.65 | | 7,071.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 26/11/2009 | |
| Chief Executive Officer | 48 | 04/01/2020 | |
| Director of Finance/CFO | 65 | 01/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 26/11/2009 | |
| Chairman | 75 | 26/11/2009 | |
| Director/Board Member | 68 | 01/10/1994 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -4.43% | +6.89% | +89.71% | 1.87TCr | |
| -3.76% | -4.81% | +38.33% | +185.65% | 92TCr | |
| +0.47% | +6.72% | +51.46% | +26.60% | 53TCr | |
| -2.32% | -3.29% | +26.50% | +41.11% | 38TCr | |
| +0.46% | +1.86% | +30.01% | +18.51% | 37TCr | |
| -2.23% | -1.06% | +31.72% | +20.33% | 29TCr | |
| -1.36% | +0.63% | +26.39% | +35.48% | 27TCr | |
| -0.04% | -0.02% | +10.87% | -1.14% | 28TCr | |
| -3.45% | -1.39% | -39.64% | -22.02% | 25TCr | |
| +0.32% | -0.02% | +22.72% | +21.46% | 18TCr | |
| Average | -1.24% | -0.57% | +20.52% | +41.57% | 34.93TCr | |
| Weighted average by Cap. | -1.66% | -0.59% | +27.90% | +64.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11TCr 118.58Cr 102.14Cr 95Cr 89Cr 164.75Cr 176.73Cr 1.09TCr 430.37Cr 5.12TCr 444.65Cr 435.55Cr 19TCr | 13TCr 139.2Cr 119.91Cr 111.75Cr 103.96Cr 193.4Cr 207.47Cr 1.28TCr 505.22Cr 6.01TCr 521.98Cr 511.3Cr 22TCr |
| Net income | 2.59TCr 29Cr 25Cr 23Cr 21Cr 40Cr 43Cr 264.48Cr 104.07Cr 1.24TCr 107.52Cr 105.32Cr 4.54TCr | 3.16TCr 35Cr 30Cr 28Cr 26Cr 49Cr 52Cr 322.13Cr 126.76Cr 1.51TCr 130.96Cr 128.28Cr 5.53TCr |
| Net Debt | -3.56TCr -39Cr -34Cr -32Cr -29Cr -55Cr -59Cr -363.01Cr -142.84Cr -1.7TCr -147.58Cr -144.56Cr -6.24TCr | -3.98TCr -44Cr -38Cr -35Cr -33Cr -61Cr -66Cr -406.29Cr -159.87Cr -1.9TCr -165.17Cr -161.8Cr -6.98TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 6,323.00 ₹ | -0.51% | 1,64,928 |
| 14/26/14 | 6,355.50 ₹ | -1.26% | 5,24,643 |
| 13/26/13 | 6,436.50 ₹ | -0.76% | 2,53,726 |
| 12/26/12 | 6,485.50 ₹ | -1.98% | 6,65,870 |
| 09/26/09 | 6,616.50 ₹ | +0.24% | 3,51,042 |
Delayed Quote NSE India S.E., January 16, 2026 at 12:00 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIVISLAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition